Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series

被引:9
作者
Cantarini, Luca [1 ]
Lucherini, Orso Maria [2 ]
Cimaz, Rolando [3 ]
Rigante, Donato [4 ]
Baldari, Cosima Tatiana [2 ]
Pasini, Franco Laghi [5 ]
Galeazzi, Mauro [1 ]
机构
[1] Univ Siena, Rheumatol Unit, Policlin Le Scotte,Inst Rheumatol, Interdept Res Ctr Syst Autoimmune & Autoinflammat, I-53100 Siena, Italy
[2] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy
[3] Univ Florence, Anna Meyer Childrens Hosp, Dept Paediat, Rheumatol Unit, Florence, Italy
[4] Univ Cattolica Sacro Cuore, Dept Pediat Sci, Rome, Italy
[5] Univ Siena, Immunol Sci Unit, Policlin Le Scotte, Interdept Res Ctr Syst Autoimmune & Autoinflammat, I-53100 Siena, Italy
关键词
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS); Periodic fever syndrome; TNFRSF1A gene mutations; Etanercept; TNF RECEPTOR; SYNDROME TRAPS; HETEROGENEITY; ACTIVATION; FAMILY; FEVER;
D O I
10.1007/s00296-010-1512-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor necrosis factor receptor-1-associated periodic syndrome (TRAPS) is the most common autosomal dominant autoinflammatory disorder and is caused by mutations in the TNFRSF1A gene encoding the 55-kDa receptor for tumor necrosis factor (TNF)-alpha. TRAPS is characterized by recurrent attacks of fever, typically lasting from 1 to 3 weeks. In addition to fever, common clinical features include periorbital edema, a migratory erythematous plaque simulating erysipela with underlying myalgia, and arthralgia or arthritis. Serosal membrane inflammation is also a common feature, usually in the form of polyserositis. To date, at least 40 different TNFRSF1A mutations have been identified, but few patients with symptoms highly suggestive of TRAPS with no mutations in the TNFRSF1A gene have recently been described, thus suggesting that not all mutations are yet known or that alternative mechanisms might be involved in the pathogenesis of the disease. We report on three such patients here.
引用
收藏
页码:4015 / 4018
页数:4
相关论文
共 18 条
[1]   Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes [J].
Aganna, E ;
Hammond, L ;
Hawkins, PN ;
Aldea, A ;
McKee, SA ;
van Amstel, HKP ;
Mischung, C ;
Kusuhara, K ;
Saulsbury, FT ;
Lachmann, HJ ;
Bybee, A ;
McDermott, EM ;
La Regina, M ;
Arostegui, JI ;
Campistol, JM ;
Worthington, S ;
High, KP ;
Molloy, MG ;
Baker, N ;
Bidwell, JL ;
Castañer, JL ;
Whiteford, ML ;
Janssens-Korpola, PL ;
Manna, R ;
Powell, RJ ;
Woo, P ;
Solis, P ;
Minden, K ;
Frenkel, J ;
Yagüe, J ;
Mirakian, RM ;
Hitman, GA ;
McDermott, MF .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2632-2644
[2]   The tumor-necrosis-factor receptor-associated periodic syndrome:: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers [J].
Aksentijevich, I ;
Galon, J ;
Soares, M ;
Mansfield, E ;
Hull, K ;
Oh, HH ;
Goldbach-Mansky, R ;
Dean, J ;
Athreya, B ;
Reginato, AJ ;
Henrickson, M ;
Pons-Estel, B ;
O'Shea, JJ ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :301-314
[3]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[4]   A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling [J].
Chan, FKM ;
Chun, HJ ;
Zheng, LX ;
Siegel, RM ;
Bui, KL ;
Lenardo, MJ .
SCIENCE, 2000, 288 (5475) :2351-2354
[5]   Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis -: Pathogenetic and clinical implications [J].
D'Osualdo, A ;
Ferlito, F ;
Prigione, I ;
Obici, L ;
Meini, A ;
Zulian, F ;
Pontillo, A ;
Corona, F ;
Barcellona, R ;
Di Duca, M ;
Santamaria, G ;
Traverso, F ;
Picco, P ;
Baldi, M ;
Plebani, A ;
Ravazzolo, R ;
Ceccherini, I ;
Martini, A ;
Gattorno, M .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :998-1008
[6]   The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome [J].
Dodé, C ;
André, M ;
Bienvenu, T ;
Hausfater, P ;
Pêcheux, C ;
Bienvenu, J ;
Lecron, JC ;
Reinert, P ;
Cattan, D ;
Piette, JC ;
Szajnert, MF ;
Delpech, M ;
Grateau, G .
ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :2181-2188
[7]  
Dodé C, 2000, ARTHRITIS RHEUM-US, V43, P1535, DOI 10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.3.CO
[8]  
2-3
[9]  
Drewe E, 2002, CLIN EXP RHEUMATOL, V4, P71
[10]  
Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.3.CO